SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Jack Nathan Medical Corp. (JNHMF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 61/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — JNHMF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.09
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.03
Book Value / Share$0.00
Revenue / Share$0.10
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.01 |
$2.93M |
$-18.09K |
-0.6% |
| 2020 |
$-0.13 |
$3.62M |
$-134.62K |
-3.7% |
| 2021 |
$-0.19 |
$3.85M |
$-9.91M |
-257.3% |
| 2022 |
$-0.09 |
$9.64M |
$-7.81M |
-81% |
| 2023 |
$-0.08 |
$15.49M |
$-7.08M |
-45.7% |
| 2024 |
$-0.08 |
$19.14M |
$-6.64M |
-34.7% |
| 2025 |
$-0.03 |
$8.71M |
$7.46M |
85.7% |
